Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul;268(7):2327-2330.
doi: 10.1007/s00415-020-10219-5. Epub 2020 Sep 17.

A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection

Affiliations
Case Reports

A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection

Fabio Giuseppe Masuccio et al. J Neurol. 2021 Jul.

Abstract

We describe a rare case of post-infective Acute Motor Axonal Neuropathy (AMAN) variant of Guillain-Barrè Syndrome (GBS) associated with myelitis and anti-GD1b positivity after SARS-CoV-2 infection. The patient referred to the hospital reporting a history of ten days lasting moderate fever, myalgia and anosmia, with the onset of progressive quadriparesis and ascending paraesthesias in the four limbs since five days from defervescence. A chest computed tomography demonstrated interstitial pneumonia with "ground glass opacities", suggesting Coronavirus disease (COVID-19). The patient exhibited three negative reverse-transcription polymerase chain reaction (RT-PCR) nasopharyngeal swabs, while SARS-CoV-2 IgG was found in plasma. The electrophysiological examination demonstrated an AMAN and the spinal cord Magnetic Resonance Imaging (MRI) showed a T2-weighted hyperintense lesion in the posterior part of the spinal cord at the C7-D1 levels. Furthermore, anti-GD1b IgM was detected. GBS and myelitis could exceptionally develop simultaneously. Our findings reasonably support a causality link between COVID-19 and the neurological symptoms, suggesting a post-infective autoimmune reaction.

Keywords: AMAN; Antiganglioside antibodies; Guillain-barrè syndrome; Myelitis; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest relevant to this paper.

Figures

Fig. 1
Fig. 1
MRI of the spinal cord; on the left, a cylindrically shaped hyperintense lesion encompassing the C7-D1 levels in the sagittal view; on the right, the same lesion in two axial views

Similar articles

Cited by

References

    1. Wang L, Shen Y, Li M, et al. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. 2020 doi: 10.1007/s00415-020-09974-2. - DOI - PMC - PubMed
    1. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388:717–727. doi: 10.1016/S0140-6736(16)00339-1. - DOI - PubMed
    1. Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Ann Neurol. 1998;44:780–788. doi: 10.1002/ana.410440512. - DOI - PubMed
    1. Guo F, Zhang YB. Clinical features and prognosis of patients with Guillain-Barré and acute transverse myelitis overlap syndrome. Clin Neurol Neurosurg. 2019;181:127–132. doi: 10.1016/j.clineuro.2019.04.014. - DOI - PubMed
    1. Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med NEJMc2009191. 2020 doi: 10.1056/NEJMc2009191. - DOI - PMC - PubMed

Publication types

Substances